NENCI, Italo
 Distribuzione geografica
Continente #
NA - Nord America 3.030
EU - Europa 1.562
AS - Asia 636
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.229
Nazione #
US - Stati Uniti d'America 3.030
IT - Italia 683
CN - Cina 397
UA - Ucraina 270
DE - Germania 236
TR - Turchia 161
GB - Regno Unito 115
SE - Svezia 88
SG - Singapore 58
FI - Finlandia 55
FR - Francia 40
BE - Belgio 33
RU - Federazione Russa 18
IN - India 10
CZ - Repubblica Ceca 9
IR - Iran 5
ID - Indonesia 4
RO - Romania 4
AT - Austria 2
NL - Olanda 2
AL - Albania 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
IE - Irlanda 1
JP - Giappone 1
PL - Polonia 1
PT - Portogallo 1
Totale 5.229
Città #
Woodbridge 367
Chandler 321
Jacksonville 294
Ann Arbor 274
Fairfield 263
Houston 204
Ashburn 163
Wilmington 114
Izmir 111
Seattle 99
Cambridge 89
Nanjing 84
Beijing 63
New York 62
Princeton 62
Bremen 60
Milan 49
Dearborn 47
Shanghai 40
Singapore 39
Nanchang 34
Brussels 32
Rome 32
Boardman 30
San Diego 29
Ferrara 28
Hebei 28
Tianjin 25
Shenyang 22
San Mateo 18
Auburn Hills 15
Changsha 15
Falls Church 15
Jiaxing 12
Jinan 12
Zhengzhou 12
Bologna 11
Hefei 11
Kunming 9
Napoli 9
Brno 8
Guangzhou 8
Naples 8
Palermo 8
Bari 7
London 7
Norwalk 7
Orange 7
Verona 7
Florence 6
Los Angeles 6
Munich 6
Parma 6
Philadelphia 6
Trento 6
Leawood 5
Ningbo 5
Padova 5
Redwood City 5
Reggio Emilia 5
Ardabil 4
Catania 4
Chicago 4
Chieti 4
Dallas 4
Foligno 4
Forlì 4
Genoa 4
Jakarta 4
Messina 4
Monmouth Junction 4
Mountain View 4
Siena 4
Taizhou 4
Torino 4
Washington 4
Caserta 3
Deiva Marina 3
Fano 3
Hangzhou 3
Imola 3
Mumbai 3
New Delhi 3
Perugia 3
Prato 3
Tappahannock 3
Acton 2
Angri 2
Bacoli 2
Battipaglia 2
Camogli 2
Chongqing 2
Des Moines 2
Fucecchio 2
Indiana 2
Lamezia Terme 2
Lanuvio 2
Olgiate Comasco 2
Oria 2
Pavia 2
Totale 3.454
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 522
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 271
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 127
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 122
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 121
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 113
null 107
Modulation of biomarkers in minimal breast carcinoma 105
High incidence of ependymomas induced by BK virus, a human papovavirus: brief communication. 98
null 98
Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology 97
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 96
Registro Tumori della provincia di Ferrara 95
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 95
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 94
null 93
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 93
The 70 Gene Mammaprint signature: Ferrara's experience 93
Espressione dei MicroRNA nei carcinomi mammari 88
[Aneurysmatic fibrous histiocytoma: case report and reivew of the literature] 86
null 86
null 85
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 84
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 84
Italy, Ferrara province 84
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 84
Sentinel node and bone marrow micro metastases and nanometastases 84
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 83
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 81
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 80
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 79
Diagnosi citologica molecolare integrata (reflex test) nella patologia neoplastica dell'urotelio. 78
Quantitative analysis of molecular markers MCM2, TOPO2A and KI-67 (Mib1) in squamous intraepithelial neoplasia in liquid-based cytology 77
Quantitative immunoprofiles of breast cancer performed by image analysis 77
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 76
null 75
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 73
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 72
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 69
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 68
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 65
Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes 64
null 64
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 63
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 63
Markers of DNA-replication licensing systems in cervical dysplasia 58
Cancer Incidence in Ferrara Province (1998-2002) 58
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 57
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 53
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 52
Italy, Ferrara province 49
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 48
Italy, Ferrara 48
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 47
Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11 41
Italy, Ferrara Province 40
null 32
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 25
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 20
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 19
Biological staging of incipient, in situ and invasive breast carcinomas 17
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 17
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 17
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 16
MicroRNA gene expression deregulation in human breast cancer 16
Linkage of biopsy, cancer, and population records aimed at the estimation of family risks in neoplasia: A pilot study 14
Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods 12
Immunohistochemistry expression of c-erbB-2 in human breast cancer by monoclonal antibody: Correlation with lymph node and ER status 10
Monoclonal Antibodies for Specific Immunoperoxidase Detection of Campylobacter pylori 1
Totale 5.279
Categoria #
all - tutte 18.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.685
Totale 20.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.031 209 33 28 132 51 130 89 116 59 107 56 21
2020/2021652 72 64 29 87 20 63 16 74 10 68 114 35
2021/2022685 18 74 32 60 65 19 18 48 23 46 60 222
2022/2023775 60 70 31 94 163 109 28 57 81 11 39 32
2023/2024409 44 24 32 16 24 101 17 40 8 9 19 75
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 5.279